Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors

Clinical trial NCT05302921 · COMPLETED

Trial details

NCT number: NCT05302921
Sponsor: Children's National Research Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Osteosarcoma Ewing Sarcoma Rhabdomyosarcoma Relapsed Pediatric Solid Tumor Refractory Pediatric Solid Tumor Melanoma Hepatoblastoma Hepatocellular Carcinoma Neuroblastoma Wilms Tumor

Start date: 2022-02-18
Primary completion: 2024-03-12
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.